| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Joana Pissarra | Q40432560 |
| Rachel Bras-Gonçalves | Q56568693 | ||
| P2093 | author name string | Philippe Vincendeau | |
| Philippe Holzmuller | |||
| Valérie Rodrigues | |||
| Jean-Loup Lemesre | |||
| Anne Geiger | |||
| Frédéric-Antoine Dauchy | |||
| Romaric Nzoumbou-Boko | |||
| Sarra Hamrouni | |||
| P2860 | cites work | Proteomic analysis of the secretome of Leishmania donovani | Q21184106 |
| Experimental Vaccines against Chagas Disease: A Journey through History | Q21284503 | ||
| Arginine metabolism: nitric oxide and beyond | Q24531285 | ||
| Exploring the full spectrum of macrophage activation | Q24653754 | ||
| Interactions between Trypanosoma cruzi Secreted Proteins and Host Cell Signaling Pathways | Q26749609 | ||
| Mechanisms of cellular invasion by intracellular parasites | Q27010243 | ||
| Formiminoglutamase from Trypanosoma Cruzi Is An Arginase-Like Manganese Metalloenzyme | Q27680665 | ||
| Nitric oxide: Protein tyrosine phosphorylation and protein S-nitrosylation in cancer | Q28082217 | ||
| Modulation of the Immune Response by Nematode Secreted Acetylcholinesterase Revealed by Heterologous Expression in Trypanosoma musculi | Q28109690 | ||
| Trypanosomes lacking trypanothione reductase are avirulent and show increased sensitivity to oxidative stress | Q28144631 | ||
| M-1/M-2 macrophages and the Th1/Th2 paradigm | Q28145893 | ||
| The Trypanosoma cruzi protease cruzain mediates immune evasion | Q28476751 | ||
| Cathepsin B gene disruption induced Leishmania donovani proteome remodeling implies cathepsin B role in secretome regulation | Q28535124 | ||
| Leishmania eukaryotic initiation factor (LeIF) inhibits parasite growth in murine macrophages | Q28538886 | ||
| An Arginine Deprivation Response Pathway Is Induced in Leishmania during Macrophage Invasion | Q28551602 | ||
| Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells | Q28565927 | ||
| Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins | Q29547534 | ||
| The M1 and M2 paradigm of macrophage activation: time for reassessment | Q29615845 | ||
| Macrophage activation and polarization | Q29616353 | ||
| Advances in leishmaniasis | Q29617229 | ||
| Macrophage activation and polarization: nomenclature and experimental guidelines | Q29620642 | ||
| Extracellular Vesicles from Trypanosoma brucei Mediate Virulence Factor Transfer and Cause Host Anemia | Q30698901 | ||
| Adult blood-feeding tsetse flies, trypanosomes, microbiota and the fluctuating environment in sub-Saharan Africa | Q30877850 | ||
| Approaches for the identification of potential excreted/secreted proteins of Leishmania major parasites | Q33230676 | ||
| Purification and characterisation of an extracellularly released protease of Trypanosoma brucei | Q33328661 | ||
| Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites | Q38678821 | ||
| Age-related alteration of arginase activity impacts on severity of leishmaniasis | Q33334323 | ||
| Proteophosophoglycans regurgitated by Leishmania-infected sand flies target the L-arginine metabolism of host macrophages to promote parasite survival | Q33495567 | ||
| Proteomic characterization of the released/secreted proteins of Leishmania (Viannia) braziliensis promastigotes | Q33496387 | ||
| Exocytosis and protein secretion in Trypanosoma. | Q33526674 | ||
| Leishmania Exosomes Modulate Innate and Adaptive Immune Responses through Effects on Monocytes and Dendritic Cells | Q33706138 | ||
| Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for L-arginine utilization | Q33731987 | ||
| The human African trypanosomiasis control and surveillance programme of the World Health Organization 2000-2009: the way forward | Q33834072 | ||
| Polyamines: mysterious modulators of cellular functions | Q33920552 | ||
| Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival | Q33950123 | ||
| The Parasite-Specific Trypanothione Metabolism of Trypanosoma and Leishmania | Q33966094 | ||
| L-Arginine availability modulates local nitric oxide production and parasite killing in experimental trypanosomiasis | Q34007809 | ||
| Regulation of nitric oxide production by arginine metabolic enzymes | Q34023598 | ||
| Cell biology of Leishmania spp.: invading and evading. | Q34115514 | ||
| Progressive visceral leishmaniasis is driven by dominant parasite-induced STAT6 activation and STAT6-dependent host arginase 1 expression | Q34139938 | ||
| L-arginine deprivation impairs Leishmania major-specific T-cell responses | Q34167773 | ||
| Vaccination against trypanosomiasis: can it be done or is the trypanosome truly the ultimate immune destroyer and escape artist? | Q34243439 | ||
| Local increase of arginase activity in lesions of patients with cutaneous leishmaniasis in Ethiopia | Q34312411 | ||
| Trypanothione biosynthesis in Leishmania major | Q34378267 | ||
| A recombinant protein based on Trypanosoma cruzi P21 enhances phagocytosis | Q34516532 | ||
| Trypanosome hydrolases and the blood-brain barrier | Q34535045 | ||
| Arginase activity in the blood of patients with visceral leishmaniasis and HIV infection | Q34563619 | ||
| Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens | Q34657537 | ||
| Biological roles of proteases in parasitic protozoa | Q34667427 | ||
| The phosphoarginine energy-buffering system of trypanosoma brucei involves multiple arginine kinase isoforms with different subcellular locations | Q34776033 | ||
| Recent advances in arginine metabolism: roles and regulation of the arginases | Q34985733 | ||
| Atypical human infections by animal trypanosomes | Q34999783 | ||
| A Trypanosoma brucei kinesin heavy chain promotes parasite growth by triggering host arginase activity | Q35034254 | ||
| SMAD-PI3K-Akt-mTOR pathway mediates BMP-7 polarization of monocytes into M2 macrophages | Q35078311 | ||
| The increase in mannose receptor recycling favors arginase induction and Trypanosoma cruzi survival in macrophages | Q35565148 | ||
| The interaction of Leishmania species with macrophages | Q35669738 | ||
| Immunomodulatory Effects of Four Leishmania infantum Potentially Excreted/Secreted Proteins on Human Dendritic Cells Differentiation and Maturation | Q35845442 | ||
| Novel Markers to Delineate Murine M1 and M2 Macrophages | Q35877268 | ||
| Deprivation of L-Arginine Induces Oxidative Stress Mediated Apoptosis in Leishmania donovani Promastigotes: Contribution of the Polyamine Pathway | Q35903818 | ||
| γ-Tilmanocept, a New Radiopharmaceutical Tracer for Cancer Sentinel Lymph Nodes, Binds to the Mannose Receptor (CD206). | Q35979023 | ||
| Infection of C57BL/10ScCr and C57BL/10ScNCr mice with Leishmania major reveals a role for Toll-like receptor 4 in the control of parasite replication | Q43920775 | ||
| Arginase I induction in macrophages, triggered by Th2-type cytokines, supports the growth of intracellular Leishmania parasites. | Q43975563 | ||
| Biogenesis of Leishmania-harbouring parasitophorous vacuoles following phagocytosis of the metacyclic promastigote or amastigote stages of the parasites. | Q43990185 | ||
| Alternative activation and increase of Trypanosoma cruzi survival in murine macrophages stimulated by cruzipain, a parasite antigen. | Q44178074 | ||
| Proteomic analysis of Trypanosoma cruzi secretome: characterization of two populations of extracellular vesicles and soluble proteins. | Q44316258 | ||
| Arginine kinase overexpression improves Trypanosoma cruzi survival capability. | Q44641510 | ||
| Arginase induction promotes Trypanosoma cruzi intracellular replication in Cruzipain-treated J774 cells through the activation of multiple signaling pathways | Q44768878 | ||
| Subcellular localization of Trypanosoma cruzi arginine kinase. | Q45920575 | ||
| Murine cutaneous leishmaniasis: susceptibility correlates with differential expansion of helper T-cell subsets | Q46136895 | ||
| Virulence and pathogenicity patterns of Trypanosoma brucei gambiense field isolates in experimentally infected mouse: differences in host immune response modulation by secretome and proteomics | Q46260367 | ||
| Arginase activity of Leishmania isolated from patients with cutaneous leishmaniasis. | Q46332681 | ||
| L-arginine availability and arginase activity: Characterization of amino acid permease 3 in Leishmania amazonensis. | Q46343959 | ||
| Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes | Q46394444 | ||
| Characterization of a 21kDa protein from Trypanosoma cruzi associated with mammalian cell invasion. | Q46642120 | ||
| Mouse strain susceptibility to trypanosome infection: an arginase-dependent effect | Q46650807 | ||
| Inducible nitric oxide synthase and nitrotyrosine in the central nervous system of mice chronically infected with Trypanosoma brucei brucei | Q46723958 | ||
| Arginase expression modulates nitric oxide production in Leishmania (Leishmania) amazonensis | Q47137720 | ||
| Arginine and Polyamines Fate in Leishmania Infection. | Q49230063 | ||
| Shedding light on the cell biology of extracellular vesicles | Q50018560 | ||
| Polyamine-trypanothione pathway: an update. | Q38783627 | ||
| Emerging roles for extracellular vesicles in parasitic infections | Q38840607 | ||
| Assessing the patterns of health-seeking behaviour and awareness among sleeping-sickness patients in eastern Uganda | Q38881928 | ||
| Conflict and human African trypanosomiasis | Q38906031 | ||
| Leishmania exosomes and other virulence factors: Impact on innate immune response and macrophage functions | Q38921225 | ||
| Sending a message: extracellular vesicles of pathogenic protozoan parasites | Q38951125 | ||
| In vitro induction of microglial and endothelial cell apoptosis by cerebrospinal fluids from patients with human African trypanosomiasis | Q39024438 | ||
| Arginine Metabolism Revisited. | Q39033964 | ||
| Identification of total and differentially expressed excreted-secreted proteins from Trypanosoma congolense strains exhibiting different virulence and pathogenicity | Q39034704 | ||
| C-type lectins: their network and roles in pathogen recognition and immunity | Q39045109 | ||
| Host cell signalling and leishmania mechanisms of evasion. | Q39113003 | ||
| Arginine Metabolism in Myeloid Cells Shapes Innate and Adaptive Immunity | Q39146030 | ||
| Immunobiology of Nitric Oxide and Regulation of Inducible Nitric Oxide Synthase | Q39271619 | ||
| The transcriptomic analytical level determines the human monocyte-derived macrophage response toward either the infectious agent or the host | Q39298947 | ||
| The C-type lectin receptors dectin-1, MR, and SIGNR3 contribute both positively and negatively to the macrophage response to Leishmania infantum | Q39301725 | ||
| The immune regulation in cancer by the amino acid metabolizing enzymes ARG and IDO. | Q39336096 | ||
| Leishmania major lipophosphoglycan: discrepancy in Toll-like receptor signaling | Q39796878 | ||
| l-Arginine Uptake by Cationic Amino Acid Transporter Promotes Intra-Macrophage Survival of Leishmania donovani by Enhancing Arginase-Mediated Polyamine Synthesis | Q40097757 | ||
| Trypanosoma musculi Infection in Mice Critically Relies on Mannose Receptor-Mediated Arginase Induction by a TbKHC1 Kinesin H Chain Homolog. | Q40121679 | ||
| Leishmanial excreted factors and their possible biological role | Q40163077 | ||
| MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll‐like receptor 2 signaling | Q40630648 | ||
| Resveratrol inhibits Trypanosoma cruzi arginine kinase and exerts a trypanocidal activity. | Q40755918 | ||
| The proteases and pathogenicity of parasitic protozoa | Q40788600 | ||
| Arginase modulates nitric oxide production in activated macrophages. | Q41066421 | ||
| The expanding universe of T-cell subsets: Th1, Th2 and more. | Q41120396 | ||
| Extracellular Vesicles: Evolutionarily Conserved Mediators of Intercellular Communication | Q41687659 | ||
| Trans-sialidase-based vaccine candidate protects against Trypanosoma cruzi infection, not only inducing an effector immune response but also affecting cells with regulatory/suppressor phenotype. | Q41709177 | ||
| Arginase I induction during Leishmania major infection mediates the development of disease | Q42005264 | ||
| Functional interplay between protein arginine methyltransferases in Trypanosoma brucei | Q42125382 | ||
| Secretome analysis of Trypanosoma cruzi by proteomics studies | Q42369579 | ||
| Human African trypanosomiasis in areas without surveillance | Q42407749 | ||
| An experimental approach for the identification of conserved secreted proteins in trypanosomatids | Q42922068 | ||
| Redirection of the immune response to the functional catalytic domain of the cystein proteinase cruzipain improves protective immunity against Trypanosoma cruzi infection | Q43055684 | ||
| Arginine methylation of a mitochondrial guide RNA binding protein from Trypanosoma brucei | Q43796392 | ||
| Why the need and how to approach the functional diversity of extracellular vesicles. | Q50578329 | ||
| Effective humoral and cellular immunoprotective responses in Li ESAp-MDP vaccinated protected dogs. | Q51945644 | ||
| Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response. | Q54111717 | ||
| The nature of immunosuppression in Trypanosoma brucei infections in mice. I. The role of the macrophage. | Q54453419 | ||
| Formation of Nitrosyl Hemoglobin and Nitrotyrosine during Murine Leishmaniasis | Q56794575 | ||
| Chagas' Disease | Q57985262 | ||
| Chagas disease | Q58842312 | ||
| Human African trypanosomiasis | Q58843356 | ||
| Inducible nitric oxide synthase and arginase expression in heart tissue during acute Trypanosoma cruzi infection in mice: arginase I is expressed in infiltrating CD68+ macrophages | Q58844652 | ||
| [Macrophages and arginase induction as a mechanism for parasite escape] | Q58845088 | ||
| Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: Double-blind randomised efficacy field trial | Q58853389 | ||
| Secretome of Animal Trypanosomes | Q58867009 | ||
| Comparing acute and chronic human cutaneous leishmaniasis caused by Leishmania major and Leishmania tropica focusing on arginase activity | Q59274608 | ||
| Albumin nitrosylated by activated macrophages possesses antiparasitic effects neutralized by anti-NO-acetylated-cysteine antibodies | Q71929931 | ||
| TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis | Q79946716 | ||
| Cutaneous leishmaniasis | Q80832717 | ||
| Distinct pattern of immunophenotypic features of innate and adaptive immunity as a putative signature of clinical and laboratorial status of patients with localized cutaneous leishmaniasis | Q84600008 | ||
| Recombinant Forms of Leishmania amazonensis Excreted/Secreted Promastigote Surface Antigen (PSA) Induce Protective Immune Responses in Dogs. | Q36028999 | ||
| NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs. | Q36229299 | ||
| Arginine and Lysine Transporters Are Essential for Trypanosoma brucei | Q36237927 | ||
| RNA-seq de novo Assembly Reveals Differential Gene Expression in Glossina palpalis gambiensis Infected with Trypanosoma brucei gambiense vs. Non-Infected and Self-Cured Flies | Q36275155 | ||
| Leishmania pifanoi proteoglycolipid complex P8 induces macrophage cytokine production through Toll-like receptor 4. | Q36593911 | ||
| STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients | Q36733391 | ||
| Macrophage M1/M2 polarization dynamically adapts to changes in cytokine microenvironments in Cryptococcus neoformans infection | Q36935291 | ||
| Serum arginase, a biomarker of treatment efficacy in human African trypanosomiasis | Q36971133 | ||
| Trypanosoma brucei Parasites Occupy and Functionally Adapt to the Adipose Tissue in Mice | Q37000564 | ||
| Proteases in parasitic diseases | Q37014808 | ||
| Toll-like receptor 4 contributes to efficient control of infection with the protozoan parasite Leishmania major | Q37116125 | ||
| The Trypanosoma brucei gambiense secretome impairs lipopolysaccharide-induced maturation, cytokine production, and allostimulatory capacity of dendritic cells | Q37123713 | ||
| Development of novel arginase inhibitors for therapy of endothelial dysfunction | Q37176702 | ||
| Distinct roles for MyD88 and Toll-like receptor 2 during Leishmania braziliensis infection in mice | Q37256528 | ||
| Macrophage polarization in bacterial infections | Q37259940 | ||
| Arginine homeostasis and transport in the human pathogen Leishmania donovani. | Q37338947 | ||
| Alternative activation of macrophages: immune function and cellular biology | Q37407476 | ||
| Visceral Leishmaniasis Patients Display Altered Composition and Maturity of Neutrophils as well as Impaired Neutrophil Effector Functions | Q37447272 | ||
| Excreted/secreted proteins from trypanosome procyclic strains. | Q37462293 | ||
| Arginase Is Essential for Survival of Leishmania donovani Promastigotes but Not Intracellular Amastigotes | Q37546985 | ||
| Leishmania (Leishmania) amazonensis induces macrophage miR-294 and miR-721 expression and modulates infection by targeting NOS2 and L-arginine metabolism. | Q37690218 | ||
| Polyamine metabolism in Leishmania: from arginine to trypanothione | Q37761657 | ||
| Role of trypanosomatid's arginase in polyamine biosynthesis and pathogenesis | Q37950217 | ||
| Leishmania exosomes deliver preemptive strikes to create an environment permissive for early infection | Q38037535 | ||
| Targeting C-type lectin receptors with multivalent carbohydrate ligands | Q38111155 | ||
| Arginase in Leishmania. | Q38165059 | ||
| Leishmaniasis in immunosuppressed individuals | Q38180754 | ||
| Arginine kinase: a potential pharmacological target in trypanosomiasis | Q38229071 | ||
| Ectosomes and exosomes: shedding the confusion between extracellular vesicles | Q38356431 | ||
| Leishmania mexicana promastigotes inhibit macrophage IL-12 production via TLR-4 dependent COX-2, iNOS and arginase-1 expression | Q38435511 | ||
| Insight into the Exoproteome of the Tissue-Derived Trypomastigote form of Trypanosoma cruzi. | Q38440096 | ||
| Current status of trypanosomiasis | Q38503222 | ||
| Dual role of arginine metabolism in establishing pathogenesis | Q38512810 | ||
| Cutaneous and mucocutaneous leishmaniasis: Clinical perspectives | Q38633536 | ||
| ??? | Q37996396 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | amino acid | Q8066 |
| trypanosomiasis | Q2443552 | ||
| cell | Q7868 | ||
| host microbial interaction | Q68260314 | ||
| hemic and immune systems | Q70202933 | ||
| protozoan proteins | Q76505803 | ||
| P304 | page(s) | 778 | |
| P577 | publication date | 2018-04-20 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Trypanosomatid Infections: How Do Parasites and Their Excreted-Secreted Factors Modulate the Inducible Metabolism of l-Arginine in Macrophages? | |
| P478 | volume | 9 |
| Q60961033 | Immunosuppression in Experimental Chagas Disease Is Mediated by an Alteration of Bone Marrow Stromal Cell Function During the Acute Phase of Infection |
| Q92635722 | Pathogens MenTORing Macrophages and Dendritic Cells: Manipulation of mTOR and Cellular Metabolism to Promote Immune Escape |
Search more.